FR2760014B1 - Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
FR2760014B1
FR2760014B1 FR9702360A FR9702360A FR2760014B1 FR 2760014 B1 FR2760014 B1 FR 2760014B1 FR 9702360 A FR9702360 A FR 9702360A FR 9702360 A FR9702360 A FR 9702360A FR 2760014 B1 FR2760014 B1 FR 2760014B1
Authority
FR
France
Prior art keywords
alkyl
novel
preparation
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9702360A
Other languages
English (en)
French (fr)
Other versions
FR2760014A1 (fr
Inventor
Jean Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Priority to FR9702360A priority Critical patent/FR2760014B1/fr
Priority to PL98324982A priority patent/PL190240B1/pl
Priority to BR9800763-7A priority patent/BR9800763A/pt
Priority to JP10042716A priority patent/JPH10237071A/ja
Priority to US09/031,490 priority patent/US5968954A/en
Priority to CA002231025A priority patent/CA2231025C/fr
Priority to HU9800422A priority patent/HU224312B1/hu
Priority to CN98107709A priority patent/CN1090627C/zh
Priority to NZ329853A priority patent/NZ329853A/xx
Priority to NO19980803A priority patent/NO314307B1/no
Priority to AT98400469T priority patent/ATE265451T1/de
Priority to ZA981680A priority patent/ZA981680B/xx
Priority to AU56359/98A priority patent/AU725756B2/en
Priority to EP98400469A priority patent/EP0861837B1/fr
Priority to ES98400469T priority patent/ES2219853T3/es
Priority to DK98400469T priority patent/DK0861837T3/da
Priority to PT98400469T priority patent/PT861837E/pt
Priority to DE69823411T priority patent/DE69823411T2/de
Publication of FR2760014A1 publication Critical patent/FR2760014A1/fr
Priority to HK99100037.7A priority patent/HK1014945B/xx
Application granted granted Critical
Publication of FR2760014B1 publication Critical patent/FR2760014B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9702360A 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Expired - Fee Related FR2760014B1 (fr)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL98324982A PL190240B1 (pl) 1997-02-27 1998-02-24 Nowe związki 2-aminoindanowe, sposób ich wytwarzania i kompozycje farmaceutyczne zawierające te związki
BR9800763-7A BR9800763A (pt) 1997-02-27 1998-02-25 Novos compostos 2-amino indano, um processo para sua preparação e composições farmacêuticas contendo os mesmos.
JP10042716A JPH10237071A (ja) 1997-02-27 1998-02-25 新規２−アミノインダン化合物、その製造法、及びそれらを含有する医薬組成物
CA002231025A CA2231025C (fr) 1997-02-27 1998-02-26 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU9800422A HU224312B1 (hu) 1997-02-27 1998-02-26 2-Amino-indán-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
CN98107709A CN1090627C (zh) 1997-02-27 1998-02-26 2－氨基－1,2－二氢化茚化合物其制备方法和药物组合物
NZ329853A NZ329853A (en) 1997-02-27 1998-02-26 4-piperidinyl substituted 2-amino indane derivatives and medicaments
NO19980803A NO314307B1 (no) 1997-02-27 1998-02-26 Nye 2-aminoindanforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholder dem
US09/031,490 US5968954A (en) 1997-02-27 1998-02-26 2-aminoindan compounds as 5HT1B antagonists
AT98400469T ATE265451T1 (de) 1997-02-27 1998-02-27 2-aminoidan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
AU56359/98A AU725756B2 (en) 1997-02-27 1998-02-27 New 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them
EP98400469A EP0861837B1 (fr) 1997-02-27 1998-02-27 Nouveaux composés de 2-amino indane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
ES98400469T ES2219853T3 (es) 1997-02-27 1998-02-27 Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK98400469T DK0861837T3 (da) 1997-02-27 1998-02-27 Nye forbindelser af 2-aminoindan, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
PT98400469T PT861837E (pt) 1997-02-27 1998-02-27 Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem
ZA981680A ZA981680B (en) 1997-02-27 1998-02-27 2-aminoindan compounds a process for their preparation and pharmaceutical compositions containing them
DE69823411T DE69823411T2 (de) 1997-02-27 1998-02-27 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
HK99100037.7A HK1014945B (en) 1997-02-27 1999-01-07 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FR2760014A1 FR2760014A1 (fr) 1998-08-28
FR2760014B1 true FR2760014B1 (fr) 1999-04-09

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9702360A Expired - Fee Related FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (18)

Country Link
US (1) US5968954A (enExample)
EP (1) EP0861837B1 (enExample)
JP (1) JPH10237071A (enExample)
CN (1) CN1090627C (enExample)
AT (1) ATE265451T1 (enExample)
AU (1) AU725756B2 (enExample)
BR (1) BR9800763A (enExample)
CA (1) CA2231025C (enExample)
DE (1) DE69823411T2 (enExample)
DK (1) DK0861837T3 (enExample)
ES (1) ES2219853T3 (enExample)
FR (1) FR2760014B1 (enExample)
HU (1) HU224312B1 (enExample)
NO (1) NO314307B1 (enExample)
NZ (1) NZ329853A (enExample)
PL (1) PL190240B1 (enExample)
PT (1) PT861837E (enExample)
ZA (1) ZA981680B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022230A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
NZ526697A (en) * 2001-01-16 2005-05-27 Astrazeneca Ab Therapeutic heterocyclic compounds
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
EP1408976B3 (en) 2001-07-20 2010-08-25 Psychogenics Inc. Treatment for attention-deficit hyperactivity disorder
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006062063A1 (ja) * 2004-12-08 2008-06-12 アステラス製薬株式会社 ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CA2231025C (fr) 2003-09-16
AU725756B2 (en) 2000-10-19
NO980803D0 (no) 1998-02-26
NZ329853A (en) 1999-01-28
AU5635998A (en) 1998-09-03
BR9800763A (pt) 1999-12-07
JPH10237071A (ja) 1998-09-08
PL324982A1 (en) 1998-08-31
HK1014945A1 (en) 1999-10-08
DE69823411T2 (de) 2005-02-17
HUP9800422A1 (hu) 1999-12-28
PL190240B1 (pl) 2005-11-30
CN1194983A (zh) 1998-10-07
US5968954A (en) 1999-10-19
ZA981680B (en) 1998-09-04
ES2219853T3 (es) 2004-12-01
EP0861837A1 (fr) 1998-09-02
DE69823411D1 (de) 2004-06-03
ATE265451T1 (de) 2004-05-15
CA2231025A1 (fr) 1998-08-27
NO314307B1 (no) 2003-03-03
DK0861837T3 (da) 2004-08-16
EP0861837B1 (fr) 2004-04-28
HU224312B1 (hu) 2005-07-28
FR2760014A1 (fr) 1998-08-28
PT861837E (pt) 2004-07-30
NO980803L (no) 1998-08-28
CN1090627C (zh) 2002-09-11
HU9800422D0 (en) 1998-04-28

Similar Documents

Publication Publication Date Title
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NL300396I1 (nl) Nieuwe derivaten met naftalinestructuren, werkwijze voor de bereiding ervan en de farmaceutische preparaten die deze bevatten
FR2761358B1 (fr) Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69624437D1 (de) 4,6-diarylpyrimidin-derivate und deren salze
GB9115377D0 (en) New compositions of matter
FR2724656B1 (fr) Nouveaux derives du benzopyranne, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2760014B1 (fr) Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
FR2751649B1 (fr) Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2755690B1 (fr) Nouveaux derives aminomethyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2735129B1 (fr) Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2756826B1 (fr) Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69105786D1 (de) Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen.
AU703092B2 (en) Benzene derivatives
FR2692262B1 (fr) Nouveaux nicotinates de diacylglycerols, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2751655B1 (fr) Nouveaux derives de bis-imides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2572074B1 (fr) Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant
FR2761985B1 (fr) Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta[a] naphtalene et du 2,3-dihydro-cyclopenta[e]indene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU6589796A (en) New 5,6,7,8-tetrahydronaphtho(2,3-b)furan and indano(5,6-b) furan amine compounds, processes for the preparation thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20061031